Recognizing and diagnosing heart failure in patients with HCM
Aleš Linhart, MD, PhD
Evidence-based novel therapies in HCM
Michelle Michels, MD
Optimal pharmacological management of HCM by clinical manifestations
Pablo Garcia-Pavia, MD, PhD
Staging therapy in hypertrophic cardiomyopathy patients with heart failure: New insights
ATTR-CM Management: Pearls From Recent Clinical Trials and Tailoring Therapy
Marianna Fontana, MD
Ronald Witteles, MD
ACC 2024: VOYAGER PAD Part 1
Marc P. Bonaca, MD, MPH
ACC 2024: The PIONEER AF-PCI Trial
Manesh R. Patel, MD
ACC 2024: SHASTA-2 Final Study Results
Daniel Gaudet, MD, PhD
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
Christie Ballantyne, MD
ACC 2024: VOYAGER PAD Part 2
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
Key Advances in Heart Health: Insights From the American College of Cardiology 2024 Scientific Sessions
Cutting-Edge Trials: TAVR for Small Aortic Annuli
Anene Ukaigwe, MD
Getting SMART about TAVR
Hemal Gada, MD
Pam R. Taub, MD, FACC, FASPC
Steven Yakubov, MD, MSCAI, FACC
Renuka Jain, MD
Roxana Mehran, MD
Ashish Aneja, MD
Deepak Talreja, MD, FACC
Elana Koss, MD
New TAVR Data – New TAVR Talk Track
It’s All About Patient Identification
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.